SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,393,000 | +34.5% | 19,903 | +10.8% | 0.01% | +11.1% |
| Q3 2020 | $2,523,000 | -6.4% | 17,963 | +6.8% | 0.01% | -10.0% |
| Q2 2020 | $2,695,000 | +87.0% | 16,812 | +14.1% | 0.01% | +66.7% |
| Q1 2020 | $1,441,000 | +11.6% | 14,731 | +47.1% | 0.01% | +20.0% |
| Q4 2019 | $1,291,000 | +55.2% | 10,011 | -9.3% | 0.01% | +66.7% |
| Q3 2019 | $832,000 | -54.5% | 11,038 | -8.3% | 0.00% | -57.1% |
| Q2 2019 | $1,830,000 | +78.0% | 12,041 | +39.6% | 0.01% | +75.0% |
| Q1 2019 | $1,028,000 | -24.4% | 8,627 | -30.8% | 0.00% | -42.9% |
| Q4 2018 | $1,360,000 | +10.8% | 12,460 | +64.1% | 0.01% | +40.0% |
| Q3 2018 | $1,227,000 | +88.5% | 7,594 | +54.3% | 0.01% | +66.7% |
| Q2 2018 | $651,000 | +161.4% | 4,922 | +46.4% | 0.00% | +200.0% |
| Q1 2018 | $249,000 | +13.7% | 3,361 | -14.6% | 0.00% | 0.0% |
| Q4 2017 | $219,000 | – | 3,936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |